Psychedelic Clinical Science
Igniting an International Conversation: People of Color & Psychedelics
There is a vast potential for psychedelics to help heal intergenerational trauma and move people toward wholeness.
Recently, there has been much excitement about the potential of psychedelic-assisted psychotherapy to address a multitude of mental health conditions, including depression, post-traumatic stress disorder, addiction, end-of-life anxiety, and other conditions. However, people of color have not been meaningfully included as research participants or researchers. With studies underway across the globe and expanding access to the benefits of these substances, space must be made for diverse voices and communities of color.
Oppression, poverty, and discrimination can all contribute to traumatic experiences at both individual and collective levels. These ongoing traumatic experiences — enhanced and compounded for people who exist at the intersection of multiple marginalized identities — are often under-recognized and thus under-treated. There is a vast potential for psychedelics to help heal trauma and move people toward wholeness.
Dr. Williams is working to make psychedelic medicine accessible for everyone. In addition to board certification, an inter-jurisdictional practice certificate, and licensure in two countries, Dr. Monnica Williams is a certified psychedelic therapist through the MAPS MDMA Training Program (part A-D). She also offers psychedelic-assisted therapy at her clinic in Tolland, Connecticut.
Psychedelic Science: Psychedelics are increasingly being researched for difficult mental health conditions, like depression, anxiety, trauma, and end-of-life distress. Dr. Monnica Williams at the University of Ottawa.
|
Upcoming Psychedelic Presentations
Online Training
- Williams, M. T. (recorded). Culturally-Informed Outreach & Clinical Research: MDMA-Assisted Psychotherapy for PTSD. TZK Seminars. (3 CEs)
Podcasts
Monnica Williams in San Francisco with Drs. Bia Labate (director) and Clancy Cavnar of Chacruna Institute for Psychedelic Plant Medicines. Dr. Williams serves on the Committee for Racial Equity & Access.
|
Online Articles
- Williams, M., Flores, J. & Vizziano, S. (2021, November). On Becoming a True Healer. Psychology Today.
- Williams, M., Flores, J. & Vizziano, S. (2021, November). Healers Need Teachers Too. Psychology Today.
- Strauss, D. & Williams, M. (2021, July 19). CIA Exploited Incarcerated Black Americans in Race for Mind-Control Agent. BMJ Journal of Medical Ethics.
- Williams, M. & Campbell, M. (2021, July 19). Experimental treatments changed the course of the AIDS epidemic; we need the same approach to mental illness today. The Baltimore Sun.
- Strauss, D. & Williams, M. (2021, June 15). CIA-Funded Research Exploited Black Americans in Search of “Mind-Control” Drug. Chacruna Institute.
- Bartlett, A. & Williams, M. (2020, November 11). The Cost of Omission: Dr. Valentina Wasson and Getting Our Stories Right. Chacruna Institute.
- Chen, X., Bullard, M., Duan, C., George, J. R., Ching, T., Kilpatrick, S., Sloshower, J., & Williams, M. (2020, November 6). The Cost of Exclusion in Psychedelic Research. Bill of Health, Petrie-Flom Center, Harvard Law School.
- Williams, M. & Labate, B. (2020, July 29). New Psychedelic Online Conferences and Safe Spaces for People of Color. Chacruna Institute.
- Williams, M. (2020). Why Black People Should Embrace Psychedelic Healing: Reclaiming Our Cultural Birthright. Chacruna Institute.
- Williams, M. (2019). Introducing Ayahuasca. Psychology Today.
- Williams, M. (2019, October 18). People of Color Making a Difference in Psychedelic Healing. Chacruna Institute.
- Williams, M. (2019). How White Feminists Oppress Black Women: When Feminism Functions as White Supremacy. Chacruna Institute.
- Williams, M. (2018). Psychedelic Psychotherapy Is Coming: Who Will Be Included? Psychology Today.
|
Psychedelic Science
Special Issue
Scholarly Articles
Advance Online
- De la Salle, S., Davis, D. D., Gran-Ruaz, S., Davis, A. K., & Williams, M. T. (in press). Acute and enduring effects of psychedelic use among Indigenous peoples in Canada and the United States. Canadian Psychology. https://doi.org/10.1037/cap0000338
- Ching, T., Williams, M., Reed, S., Kisicki, M., Wang, J., Yazar-Klosinski, B., Emerson, A., & Doblin, R. (in press). MDMA-assisted therapy for posttraumatic stress disorder: A mixed-methods case study of a participant of color from an open-label trial. Journal of Humanistic Psychology. https://doi.org/10.1177/00221678221076993
- Ching, T., Davis, A. K., Xin, Y., & Williams, M. T. (in press). Effects of psychedelic use on racial trauma symptoms and ethnic identity among Asians in North America. Journal of Psychoactive Drugs. https://doi.org/10.1080/02791072.2022.2025960
- Davis, A. K., Xin, Y., Sepeda, N. D., Garcia-Romeu, A., & Williams, M. T. (in press). Increases in psychological flexibility mediate the relationship between acute psychedelic effects and decreases in racial trauma symptoms among people of color. Chronic Stress. https://doi.org/10.1177/24705470211035607
- Strauss, D., de la Salle, S., Sloshower, J., & Williams, M. T. (in press). Research abuses against people of colour and other vulnerable groups in early psychedelic research. Journal of Medical Ethics. http://dx.doi.org/10.1136/medethics-2021-107262
Published
- Rochester, J., Vallely, A., Grof, P., Williams, M., Chang, H., & Caldwell, K. (2022). Entheogens and psychedelics in Canada: Proposal for a new paradigm. Canadian Psychology, 63(3), 413–430. https://doi.org/10.1037/cap0000285
- Strauss, D., Williams, M. T., Osman, M., & Gallo, J. (2022). Myths about race and racism on university campuses. In J. Faintuch & S. Faintuch (Eds.), Integrity of Scientific Research: Fraud, Misconduct and Fake News in the Academic, Medical and Social Environment (pp. 151–161). Springer. https://doi.org/10.1007/978-3-030-99680-2_16
- Rosa, W. E., Sager, Z., Miller, M., Bernstein, I., Rinaldi, A. D., Addicott, K., Ljuslin, M., Adrian, C., Back, A. L., Beachy, J., Bossis, A. P., Breitbart, W. S., Cosimano, M. P., Fischer, S. M., Guss, J., Knighton, E., Phelps, J., Richards, B. D., Richards, W. A., Tulsky, J. A., Williams, M. T., & Beaussant, Y. (2022). Top ten tips palliative care clinicians should know about psychedelic-assisted therapy in the context of serious illness. Journal of Palliative Medicine, 25(8), 1273-1281. https://www.liebertpub.com/doi/10.1089/jpm.2022.0036
- Michaels, T. I., Lester, L., de la Salle, S., & Williams, M. T. (2022). Ethnoracial inclusion in randomized, double-blind, placebo-controlled clinical trials of ketamine in the treatment of mood disorders. Journal of Studies on Alcohol and Drugs, 83(4), 596–607. https://doi.org/10.15288/jsad.2022.83.596.
- Ching, T., Williams, M., Wang, J., Jerome, L., Yazar-Klosinski, B., Emerson, A., & Doblin, R. (2022). MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from a phase 2 open-label lead-in trial and phase 3 randomized, blinded placebo-controlled trial. Journal of Psychopharmacology, 36(8), 974-986. https://doi.org/10.1177/02698811221104052
- Davis, A. K., Arterberry, B. J., Xina, Y., Agin-Liebese, G., Schwarting, C., & Williams, M. T. (2022). Race, ethnic, and sex differences in prevalence of and trends in hallucinogen consumption among lifetime users in the United States between 2015-2019. Frontiers in Epidemiology, 2, 876706. https://doi.org/10.3389/fepid.2022.876706
- Beaussant, Y., Tulsky, J., Guérin, B., Schwarz-Plaschg, C., Sanders, J., & the Radcliffe Institute for Advanced Studies Working Group on Psychedelic Research in Serious Illness. (2021). Mapping an agenda for psychedelic-assisted therapy research in patients with serious illness. Journal of Palliative Medicine, 24 (11), 1657-1666. https://doi.org/10.1089/jpm.2020.0764
- Fogg, C., Michaels, T. I., de la Salle, S., Jahn, Z. W., & Williams, M. T. (2021). Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic medicine. Experimental and Clinical Psychopharmacology, 29(5), 539–554. https://doi.org/10.1037/pha0000490
- Jahn, Z. W., Lopez, J., de la Salle, S., Faber, S., & Williams, M. T. (2021). Racial/Ethnic differences in prevalence for hallucinogen use by age cohort: Findings from the 2018 National Survey on Drug Use and Health. Journal of Psychedelic Studies, 5(2), 69-82. https://doi.org/10.1556/2054.2021.00166
- Williams, M. T. (2021). Why Black people should embrace psychedelic healing. In B. Labate & C. Cavnar (Eds.), Psychedelic Justice: Toward a Diverse and Equitable Psychedelic Culture (pp. 3-7). Synergetic Press. ISBN: 978-0907791-85-0.
- Williams, M. T. (2021). When feminism functions as White supremacy: How White feminists oppress Black women. In B. Labate & C. Cavnar (Eds.), Psychedelic Justice: Toward a Diverse and Equitable Psychedelic Culture (pp. 21-27). Synergetic Press. ISBN: 978-0907791-85-0.
- Campbell, M. & Williams, M. T. (2021). The ethic of access: An AIDS activist won public access to experimental therapies, and this must now extend to psychedelics for mental illness. Frontiers in Psychiatry, 12(680626), 1-5. https://doi.org/10.3389/fpsyt.2021.680626
- Williams, M., Davis, A., Xin, Y., Sepeda, N., Colon-Grigas, P., Sinnott, S., & Haeny, A. (2021). People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences. Drugs: Education, Prevention & Policy, 28(3), 215-226. https://doi.org/10.1080/09687637.2020.1854688
- Halstead, M., Reed, S., Krause, R., & Williams, M. T. (2021). Ketamine-assisted psychotherapy for PTSD related to experiences of racial discrimination. Clinical Case Studies, 20(4), 310-330. https://doi.org/10.1177/1534650121990894
- Williams, M. T., Bartlett, A., Michaels, T. I., Sevelius, J., & George, J. R. (2020). Dr. Valentina Wasson: Questioning what we think we know about the foundations of psychedelic science. Journal of Psychedelic Studies, 4(3), 146-148. https://doi.org/10.1556/2054.2020.00140
- Williams, M. T., Reed, S., & George, J. (2020). Culture and psychedelic psychotherapy: Ethnic and racial themes from three Black women therapists. Journal of Psychedelic Studies, 4(3), 125-138.
- Williams, M. T., Reed, S., & Aggarwal, R. (2020). Culturally-informed research design issues in a study for MDMA-assisted psychotherapy for posttraumatic stress disorder. Journal of Psychedelic Studies, 4(1), 40–50. doi: 10.1556/2054.2019.016
- George, J. R., Michaels, T. I., Sevelius, J., & Williams, M. T. (2020). The psychedelic renaissance and the limitations of a White-dominant medical framework: A call for indigenous and ethnic minority inclusion. Journal of Psychedelic Studies, 4(1), 4-15. doi: 10.1556/2054.2019.015
- Sloshower, J., Guss, J., Krause, R., Wallace, R., Williams, M., Reed, S., & Skinta, M. (2020). Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame. Journal of Contextual Behavioral Science, 15, 12-19.
- Michaels, T. I., Purdon, J., Collins, A. & Williams, M. T. (2018). Inclusion of people of color in psychedelic-assisted psychotherapy: A review of the literature. BMC Psychiatry, 18(245), 1-9. doi: 10.1186/s12888-018-1824-6.
- Williams, M. T., & Leins, C. (2016). Race-based trauma: The challenge and promise of MDMA-assisted psychotherapy. Multidisciplinary Association for Psychedelic Studies (MAPS) Bulletin, 26(1), 32-37.
|
Prior Lectures & Presentations
Dr. Monnica Williams co-organized a workshop and training for therapists of color in August 2019 for MDMA-assisted therapy for PTSD, sponsored by MAPS and grant funded by the Open Society Foundations.
|
- Williams, M. T. (2023, February 10). Psychedelics and Racial Justice. Psychedelic Assisted Psychotherapy: Promise and Perils. Harvard University, Cambridge, MA.
- Williams, M. T. (2022, November 10). Psychedelic Medicine: What Psychologists Need to Know. KPA Annual Convention, Louisville, KY.
- Williams, M. T. (2022, November 2). What to Do (and Not to Do) When Clients Talk About Using Psychedelics. School of Psychology, Clinical Program, University of Ottawa, ON.
- Williams, M. T. (2022, October 20). Psychedelics and Equity Session. McGill Palliative Care Congress, Montreal, Quebec.
- Williams, M. T. (2022, September 22-24). The Inclusion and Exploitation of People of Color in Psychedelic Research. ICPR, The Netherlands.
- Williams, M. T. (2022, July 28). Psychedelics and Racial Justice. Psychotherapy Networker. PESI.
- Williams, M. T. & Flores, J. (2022, July 2). Self-Care. Reconnection Journey: A Plant Medicine Workshop and Retreat. Olon, Ecuador.
- Williams, M. T. (2022, May 27-29). Psychedelics and Racial Justice. Plenary Talk. From Research to Reality (R2R) Global Summit on Psychedelic Assisted Therapies and Medicine. Toronto, ON.
- Williams, M. T. (2022, May 25). The Future of Inclusion in Psychedelics. Keynote lecture. Medical Psychedelics House of Davos. Davos, Switzerland.
- King, S., Williams, M., Labate, B., & Yehuda, R. (2022, May 23). Racial Justice and Equity in Healthcare. Panel presentation. Medical Psychedelics House of Davos. Davos, Switzerland.
- Schlosser, D., McCowan, J., Williams, M., Boger, J., & Albert, M. (2022, May 22). Psychedelics for Mental Health and Beyond. Panel presentation. Medical Psychedelics House of Davos. Davos, Switzerland.
- Strauss, D. & Williams, M. T. (2022, April 14). The MKUltra Project and Research Abuses of incarcerated Black Men. [Virtual]. Stanford University, CA.
- Williams, M. T. (2022, February 28). Racial Trauma, Racial Justice, and Psychedelics. Oregon Psilocybin Advisory Board. [Virtual]. Portland, OR.
- Williams, M. T. (2021, November 6). Challenging Structural Racism in Psychedelic Research. [Online presentation]. Psychedelic Medicine for Psychiatrists. Massachusetts General Hospital Psychiatry Academy, Boston, MA.
- Williams, M. T. (2021, November 4). Psychedelics and Racial Justice: Equity and Access. Psychedelic Symposium. University of Wisconsin, Madison, WI.
- Williams, M. T., Ching, T., Labate, B. (2021, October 28). Ensuring Safety in Psychedelic Medicine for All. Research2Reality Summit Planning Committee.
- Williams, M. (2021, October 21). Broadening access to psychedelic therapies. Psychedelics in Canada: Now and in the Future Conference. Canadian Network for Biomarker Integration in Depression (CAN-BIND). Online conference.
- Williams, M. T. (2021, July 27). Ayahuasca: From the Amazon to the West and Ayahuasca Tourism. Guest Lecture. Department of Religious Studies, University of Ottawa, ON.
- Williams, M. T. & Le Baron, D. (2021, June 19). Psychedelics for Racial Trauma. Doubleblind. Online presentation.
- Williams, M. T. (2021, March 2). Psychedelic Therapies, Research, and Training. Department of Cellular and Molecular Medicine, University of Ottawa, ON.
- Williams, M. T. (2021, February 10). Understanding Psychedelic-Assisted Psychotherapies: A New Frontier in Mental Health. NCR Chapter, Canadian Counselling and Psychotherapy Association.
- Pirozek, J., Williams, M. T., & Dyck, E. (2021, January 20). Chacruna in Canada: What Does Reciprocity Look Like in the North? Community Forum Series. Chacruna Institute.
- Williams, M. T. (2021, January 19). Racial Trauma and New Directions in Healing. Icahn School of Medicine at Mount Sinai.
- Williams, M. T., Davis, A. K., Davis, D. D., Marcus, O., Gorman, I., & Nielson, E. (2020, November 13). Opportunities for Psychedelic Science and Psychotherapy Training. Source Research Foundation.
- Williams, M. (2020, November 12). Ketamine-assisted psychotherapy for PTSD related to experiences of racial discrimination. In D. Bernard (chair), Identifying Barriers and Mechanisms for the Treatment of Racial Trauma Among Black Communities: Implications for Bridging Science and Practice. International Society for Traumatic Stress Studies.
- Baggott, M., Ching, T., Christie, D., & Williams, M. (2020, October 16). MDMA: Expansive Research and Applications. 2020: Vision and Visionaries, Biannual Psychedelic Psychotherapy Forum, Victoria, BC.
- Williams, M. T. (2020, October 15). Psychedelics for Racial Trauma. 2020: Vision and Visionaries, Psychedelic Psychotherapy Forum, Victoria, BC.
- Grof, S., Grof, B., Williams, M. T., Pirozek, J., Bourzat, F., Loizaga-Velder, A., Passie, T., & Millar, T. (2020, October 15). Vision for the Future of Psychedelic Psychotherapy. 2020: Vision and Visionaries, Biannual Psychedelic Psychotherapy Forum, Victoria, BC.
- Labate, B., Belser, A., Williams, M. T., & Buchanan, N. (2020, September 25). Diversity, Equity and Access in Psychedelic Medicine. Panel discussion for Interdisciplinary Conference on Psychedelic Research,Haarlem, The Netherlands.
- Davis, A. K., Williams, M. T. Sinnot, S., Gringas, P., Sepeda, N., Haeny, A. (2020, September 24). Psychedelic-occasioned decreases in trauma symptoms among people of color who have a history of racial trauma. Interdisciplinary Conference on Psychedelic Research, Haarlem, The Netherlands.
- Williams, M. T. (2020, September). Marginalized Voices, Racial Trauma, and Psychedelic Therapies. Center for Integral Studies, San Francisco, CA.
- Williams, M. T. (2020, August 31). Psychedelics. The New Health Club Show Podcast.
- Williams, M. T. (2020, August 11). Psychedelics and Social Justice. Examining the Psychedelic Renaissance webinar series. MAPS Canada.
- Morisano, D. (2020, July 30). Race and Psychedelics with Dr. Monnica Williams. Field Trip webinar.
- Williams, M. T. (2020, July 22). Racial Trauma and Psychedelic Therapy. The Maudsley Psychedelic Society, UK.
- Williams, M. T. & Labate, B. (2020, July 8). Black Lives Matter, Psychedelics and Anti-Racism. Chacruna Institute.
- Kaiser, C. (2020, June 16). An Interview with Monnica Williams: Treating Race-Based Trauma with Psychedelics & Addressing Mental Health Disparities. Think Supersystemic.
- Williams, M. T. (2020, May, 29-31). Psychedelic-Assisted Therapy and Access: Who Will be Included. Catalyst Calgary Psychedelic Research Conference, Calgary, AL. (online)
- Williams, M. T. (2020, April 25). Psychedelic Psychotherapy is Coming: Who Will be Included? Psychedelic Liberty Summit. Chacruna Institute, San Francisco, CA. (online)
- Williams, M. T. (2020, April 9). Ayahuasca for Racial Trauma: A Professional and Personal Journey. Ottawa Psychedelic Education Network, Ottawa, ON. (online)
- Williams, M. T. (2020, April 8). Psychedelic-Assisted Therapy, Access and Inclusion.
Psychedelic Liberty in Times of Crisis [Webinar]. Chacruna Institute.
- Labate, B., Williams, M. T., Conour, K. & Herzberg, G. (2020, February 25). Diversity, Equity, & Access in Psychedelic Medicine. Chacruna Institute Community Forum Series, San Francisco, CA.
- Williams, M. T. & Payer, D. (2020, February 1). Dosed Documentary. Film and Panel Discussion, Mayfair Theatre, Ottawa, ON.
- Williams, M. T. (2020, January 27-28). Exploratory seminar on psychedelic-assisted therapy for seriously ill patients. Radcliffe Institute for Advanced Study, Harvard University, Cambridge, MA.
- Williams, M. T. (2019, November 13). Can Psychedelics Heal Racial Trauma? A Profesional and Personal Journey. The Penn Society for Psychedelic Science, University of Pennsylvania, Philadelphia, PA. [invited]
- Williams, M. T. (2019, November 2). Racial Trauma and the Promise of Psychedelic Psychotherapies. Keynote lecture for Arizona Psychological Association Annual Convention, Phoenix, AZ. [invited]
- Williams, M. T. (2019, October 17-21). Culturally Informed Psychedelic Therapy. In B. Labate (Chair). Women, Diversity, and Sexual Minorities in the Psychedelic Community. Panel presentation Bioneers Conference, San Rafael, CA.
- Williams, M. T. (2019, August 10-17). MDMA Conference for Therapists and Communities of Color. Workshop Keynote lecture. Louisville, KY.
- Williams, M. T. (2018, November 28). MDMA-Assisted Psychotherapy and PTSD in Communities of Color. Inclusion of People of Color and Intersectional Feminism in Psychedelic Science. MAPS Psychedelic Science Webinar Series. [invited]
- Williams, M. T., Wetterneck, C. T., Reed, S., Siu, W., Ching, T. & George, J. (2018, November 8-10). Psychedelic Therapy for PTSD in People of Color. Panel presentation for 34th Annual Meeting of the International Society for Traumatic Stress Studies, Washington, DC.
- Williams, M. T. (2018, October 6). Race-Based Trauma: The Challenge and Promise of MDMA-Assisted Psychotherapy. Horizons: Perspectives on Psychedelics, New York City, NY. [invited]
- Pollan, M., Doblin, R., Williams, M. T., & Niño, R. (2018, October 5). Breakthrough for Psychedelic Medicine: An Intimate Dinner to Heal Trauma Through MDMA Therapy. Multidisciplinary Association of Psychedelic Studies, The Assemblage, New York City, NY. [invited]
- Williams, M. T. (2018, July 14). Sleeping Octopus Assembly on Psychedelics (SOAP). Lecture for Multidisciplinary Association of Psychedelic Studies. Pittsburgh, PA. [invited]
- Williams, M. T. (2018, May 4). Marginalized Voices, Racial Trauma, and the Psychedelic Healing Movement. Lecture, California Institute of Integral Studies, San Francisco, CA. [invited]
- Williams, M. T., Siu, W & Powers, N. (2018, April 27). Psychedelics, Therapy, and Race: A Panel Discussion. Panel Discussion, New School, New York City, NY. [invited]
- Williams, M. T. & Powers, N. (2017, November 11). Minority Inclusion in the Psychedelic Movement. Panel, Northern Regional Mini Conference, Students for Sensible Drug Policy, Yale University, New Haven, CT. [invited]
- Williams, M. T., Sevelius, J., Kahn, P. G., Red Bear, L. M., & Ali, I. (2017, April). Injustice, Intersectional Trauma, and Psychedelics. Psychedelic Science Conference, Oakland, CA.
Selected Student Poster Presentations
- Michaels, T. I., Lester, L. F., Purdon, J., & Williams, M. (2018, November). Inclusion of People of Color in Ketamine Randomized Clinical Trials for the Treatment of Depression. Poster session at the 52nd Annual Convention of the Association of Behavioral and Cognitive Therapies, Washington, DC.
- Ching, T. H. W., Williams, M. T., Kisicki, M., Reed, S. J., & George, J. (2017, November). MDMA-Assisted Psychotherapy for Treatment-Resistant PTSD: MAPS-Sponsored Phase 2 Findings & Cultural Considerations for Phase 3 Trials. Poster session at the 51st Annual Convention of the Association of Behavioral and Cognitive Therapies, San Diego, CA.
Selected Media Appearances

Life, Death, and Psychedelic Drugs:
Psychedelics are increasingly being used to treat difficult mental health issues like PTSD and for end-of-life care. Here's what the potential of these drugs in controlled treatment settings looks like, featuring Dr. Monnica Williams. Source: BEME/CNN
|
- Sanders, L. (2021, December 3).
Can psychedelics meet their potential for treating mental health disorders?
Science News.
- Dagenhardon, C. (2021, November 19). How Dr. Monnica Williams Created Canada's First Psychedelic Master's Degree Program: "Nobody Took Me Seriously". Psychedelic Spotlight.
- Red Table Talk. (2021, November 13). How Plant Medicine Can Help People of Color with Jada Pinkett Smith. FaceBook. [download here]
- Greco, F. (2021, October 4). University of Ottawa unveils virtual microprogram on psychedelic studies. The Charlatan. Carleton University Student Newspaper.
- Whelan, Z. (2021, September 22). Mental Health with a Side of Psychedelics. OZY.
- Donovan, R. (2021, August 19). Meet the Psychologist Using Psychedelics to Treat Racial Trauma. Leaps.
- Lyford, C. (2021, May/June). Psychedelic Therapy and Racial Trauma: Offering Clients a Deeper Experience of Healing. The Therapy Beat. Psychotherapy Networker.
- Betuel, E. (2021, March 22). Scientists Are Using Psychedelics to Help People Cope With Racial Trauma. Future Human.
- Pahr, K. (2021, January 29). Psychedelics Shown to Ease the Effects of Racial Trauma. Lucid News.
- Favaro, A., St. Philip, E., & Ho, S. (2021, January 26). Psychedelic drugs can help treat PTSD caused by racism, discrimination: researchers. CTV National News.
- Chambers D. (2021, January 5). Could magic mushrooms heal South Africans with racial trauma? Based on a new study, the answer could be yes. Sunday Times Daily.
- ANI. (2021, January 2). Here's how one may lessen trauma of racial injustice. Big News Network.
- Caldwell, E. (2020, December 28). One psychedelic experience may lessen trauma of racial injustice. Ohio State University News.
- Gregoire, C. (2020, October 29). Inside the Movement to Decolonize Psychedelic Pharma. NeoLife.
- Yin, S. (2020, January 10). How researchers and advocates of color are forging their own paths in psychedelic-assisted therapy. The Pulse. NPR/PBS.
- White, W. (2019, December 2). Race, Trauma and Psychedelic Therapy. The 730 . [Podcast]
- Janikian, M. (2019, December 2). Five Women in Psychedelics You Should Know About: Badass women making waves in the psychedelic movement, from research to drug policy reform. Double Blind.
- Mocerino, M. (2019, November 22). Racial Disparities: Trippy Talk with Dr. Monnica Williams. Reality Sandwich.
- Janikian, M. (2019, September 2). MDMA for Racial Trauma. Double Blind.
- Lekhtman, A. (2019, August 23). The First-Ever MDMA Therapy Training for Communities of Color Was Vital. Filter.
- Luse, B. (2019, February 4). Blue Pill. The Nod. Gimlet Media.
- Lekhtman, A. (2018, December 18). Pioneering UConn MDMA Research Focused on People of Color: Next Steps for Equity in Treatment. Psychedelic Times.
- Lekhtman, A. (2018, December 4). The Burgeoning Psychedelics Movement Still Excludes Women and People of Color. Filter.
- Rao, S. (2018, October 31). Black Scholars and Healers Use Psychedelics to Treat Race Based Trauma. ColorLines Magazine.
- Watson, E. C. (2018, October 30). Black Americans Are Building A Space In Psychedelic Drug Culture After Being Ignored For Decades. Okay Player.
- Ofgang, E. (2018, October 22). Psychedelic Drugs Show Promise For Treatment of PTSD. Connecticut Magazine.
- Sullivan, K. (2018, October 1). Black Americans Are Being Left Out of Psychedelics Research. Vice Tonic.
More media appearances »
Monnica Williams and Jade Ullmann in the MAPS Study Treatment room research space at the University of Connecticut Health Center.
|
Grants & Awards
- 2020 - MDMA-Assisted Psychotherapy Expanded Access Pilot Project for Racial Trauma in People of Color, Psychedelic Research Funders Collective
- 2019 - MDMA Therapy Training for Communities of Color, Open Society Foundations for Multidisciplinary Association for Psychedelic Studies (MAPS)
- 2018 - Cosmic Sisters Women of The Psychedelic Renaissance Grant
- 2018 - Ullmann Family Foundation
- 2017 - An Open-Label, Multi-Site Phase 2 Study of the Safety and Effect of Manualized MDMA-Assisted Psychotherapy for the Treatment of Severe Posttraumatic Stress Disorder (MP-16), MAPS
Conference Planning
- Conference Planning Team, Global Summit on Psychedelic-Assisted Therapies and Medicines: From Research to Reality, Scheduled for 2021, Toronto, ON
|